Tungs’ Medical Journal
Colchicine and cardiovascular diseases: A narrative review
By Chieh Chen and Da-ming Liao.
Abstract
Abstract Colchicine was initially an anti-inflammatory drug used to treat gout and cardiovascular diseases and alleviate acute pain by inhibiting the immune response. Despite being an old drug, it has found a new purpose because it was recently approved by the US Food and Drug Administration for treating cardiovascular diseases, along with other medications such as statins, even though in Taiwan, it is yet to be used for treating conditions such as myocardial infarction, atherosclerosis, and ischemic stroke. However, it does pose some side effects; therefore, for its use in acute gout attack or cardiovascular events, patients must always comply with the doctor’s instruction to achieve the optimal therapeutic outcome and minimize any unnecessary risks associated with medication safety.
Keywords
- anti-inflammatory effects
- atherosclerosis
- atherosclerotic cardiovascular disease
- colchicine
- gout
Source
Published in Tungs’ Medical Journal. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
